April 24, 2025

Press Release: Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

March 22, 2025

The March 2025 News from ECOG-ACRIN blog is now available

March 5, 2025

LISTEN: A JAMA Network Learning podcast interview with Dr. Anand Jillella, author of the newly published results of study EA9131 in JAMA Oncology

February 25, 2025

Top trial results of 2024: A year of significant advancements in cancer treatment by ECOG-ACRIN and PrECOG

February 6, 2025

“I was delighted when I saw the results. Positive phase 3 trials in glioma are a rarity.” David Schiff on the results of E3F05

January 17, 2025

The Winter 2025 advocacy blog Considering Clinical Trials is now available

January 10, 2025

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

ECOG-ACRIN Cancer Research Group